José Carlos Armario-Hita (J C Armario-Hita, José-Carlos Armario-Hita, Jose C Armario-Hita, Jose Carlos Armario-Hita)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Venues

Dermatology and therapy

Life (Basel, Switzerland)

The British journal of dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

University of Cádiz

University of Cádiz (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cádiz

Spain

Professor of Dermatology :: Department of Medicine. Area of Dermatology

Education History

University of Cádiz

Spain

PHD :: Department of medicine

Publications

Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José Carlos Armario-Hita
Response to "Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis'". Dermatology and therapy 14 (3) (2024)
Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José Carlos Armario-Hita
Response to "Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis'". Dermatology and therapy 14 (3) (2024)
Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José Carlos Armario-Hita
Response to "Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis'". Dermatology and therapy 14 (3) (2024)
Ricardo Ruiz Villaverde, Lourdes Rodriguez-Fernandez-Freire, Marta Cebolla-Verdugo, Alvaro Prados-Carmona, Carlos Hernández-Montoya, José Carlos Armario-Hita, Manuel Galán-Gutiérrez
Bimekizumab: Short-Term Effectiveness and Safety in Real Clinical Practice in Andalucia, Spain. Life (Basel, Switzerland) 14 (3) (2024)
Ricardo Ruiz Villaverde, Lourdes Rodriguez-Fernandez-Freire, Marta Cebolla-Verdugo, Alvaro Prados-Carmona, Carlos Hernández-Montoya, José Carlos Armario-Hita, Manuel Galán-Gutiérrez
Bimekizumab: Short-Term Effectiveness and Safety in Real Clinical Practice in Andalucia, Spain. Life (Basel, Switzerland) 14 (3) (2024)
Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José Carlos Armario-Hita
Response to "Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis'". Dermatology and therapy 14 (3) (2024)
Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José Carlos Armario-Hita
Response to "Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis'". Dermatology and therapy 14 (3) (2024)
Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José Carlos Armario-Hita
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis. Dermatology and therapy (2024)
Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José Carlos Armario-Hita
Response to "Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis'". Dermatology and therapy (2024)
Francisco Jose Navarro-Triviño, Sara Alcantara-Luna, Javier Domínguez-Cruz, Manuel Galán-Gutiérrez, Ricardo Ruiz Villaverde, José Juan Pereyra-Rodriguez, José Carlos Armario-Hita
Upadacitinib for moderate to severe atopic dermatitis. Immunotherapy (2023)
José Juan Pereyra-Rodriguez, J L Poveda, A Rivero, E Serra-Baldrich, J F Silvestre, José Carlos Armario-Hita, M Á Calleja, Y José Manuel Carrascosa, Á Flórez, P Herranz, Marta Comellas, F J Ortiz de Frutos
Assessing the value of moderate-to-severe atopic dermatitis treatment using Multi-Criteria Decision Analysis (MCDA). Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José Carlos Armario-Hita
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis. Dermatology and therapy (2023)
Ricardo Ruiz Villaverde, Fiorella Vasquez-Chinchay, Lourdes Rodriguez-Fernandez-Freire, José Carlos Armario-Hita, Amalia Pérez-Gil, Manuel Galán-Gutiérrez
Super-Responders in Moderate-Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives. Life (Basel, Switzerland) 12 (9) (2022)
Jose Manuel Dodero-Anillo, Inmaculada Concepcion Lozano-Cuadra, Esmeralda Rios-Sanchez, Maria Jose Pedrosa-Martinez, Jose Carlos Ruiz-Carrascosa, Manuel Galan-Gutierrez, José Carlos Armario-Hita
Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis. Life (Basel, Switzerland) 12 (12) (2022)
Jose Manuel Dodero-Anillo, Inmaculada Concepcion Lozano-Cuadra, Esmeralda Rios-Sanchez, Maria Jose Pedrosa-Martinez, Jose Carlos Ruiz-Carrascosa, Manuel Galan-Gutierrez, José Carlos Armario-Hita
Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis. Life (Basel, Switzerland) 12 (12) (2022)
Jose Manuel Dodero-Anillo, Inmaculada Concepcion Lozano-Cuadra, Esmeralda Rios-Sanchez, Maria Jose Pedrosa-Martinez, Jose Carlos Ruiz-Carrascosa, Manuel Galan-Gutierrez, José Carlos Armario-Hita
Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis. Life (Basel, Switzerland) 12 (12) (2022)
Matthias Augustin, Laurent Miséry, L von Kobyletzki, José Carlos Armario-Hita, S Mealing, M Redding
Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Jose Manuel Dodero-Anillo, Inmaculada Concepcion Lozano-Cuadra, Esmeralda Rios-Sanchez, Maria Jose Pedrosa-Martinez, Jose Carlos Ruiz-Carrascosa, Manuel Galan-Gutierrez, José Carlos Armario-Hita
Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis. Life (Basel, Switzerland) 12 (12) (2022)
Ricardo Ruiz Villaverde, Javier Domínguez-Cruz, Francisco Jose Navarro-Triviño, Manuel Galán-Gutiérrez, José Carlos Armario-Hita, José Juan Pereyra-Rodriguez
Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders). Life (Basel, Switzerland) 12 (8) (2022)
J García-Gavín, Pedro Mercader Garcìa, Miguel Ángel Gallego Descalzo, Ignacio García Doval, J F Silvestre, J Sánchez-Pérez, V Fernández-Redondo, José Carlos Armario-Hita, Inmaculada Ruiz-Gonzalez, Gimenez-Arnau Ana Maria
Efficiency in patch testing: the number needed to test to get one relevant result as a new approach in the evaluation of baseline series. The British journal of dermatology 183 (2) (2020)
J J Pereyra-Rodriguez, J Domínguez-Cruz, Ricardo Ruiz Villaverde, J F Silvestre, M Galán, Laia Curto-Barredo, I Figueras, E Serra-Baldrich, José Carlos Armario-Hita
Drug survival of systemic and biological treatments for moderate-to-severe atopic dermatitis in adults: a multicentre retrospective observational study. The British journal of dermatology 184 (1) (2020)
José Carlos Armario-Hita, J Pereyra-Rodriguez, J F Silvestre, Ricardo Ruiz Villaverde, A Valero, R Izu-Belloso, I Jáuregui-Presa, Laia Curto-Barredo, I Figueras-Nart, P Herranz-Pinto, L Herraez-Herrera, F J Ortiz-de-Frutos, L Martinez-Pilar, Joaquin Sastre, E Serra-Baldrich
Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series. The British journal of dermatology 181 (5) (2019)

José Carlos Armario-Hita.css-eqlu8i{font-size:small;padding-left:4px;} (J C Armario-Hita, José-Carlos Armario-Hita, Jose C Armario-Hita, Jose Carlos Armario-Hita)

Publication Activity (10 Years)

Top Topics

Top Venues

José Carlos Armario-Hita (J C Armario-Hita, José-Carlos Armario-Hita, Jose C Armario-Hita, Jose Carlos Armario-Hita)